Total Payments
$207,554
2024 Payments
$207,044
Companies
14
Transactions
23
Medicare Patients
9,903
Medicare Billing
$668,432
Payment Breakdown by Category
Research$206,884 (99.7%)
Food & Beverage$593.55 (0.3%)
Education$76.14 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $206,884 | 1 | 99.7% |
| Food and Beverage | $593.55 | 19 | 0.3% |
| Education | $76.14 | 3 | 0.0% |
Payments by Type
Research
$206,884
1 transactions
General
$669.69
22 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Provepharm Inc. | $206,884 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $151.21 | 6 | $0 (2020) |
| Janssen Biotech, Inc. | $141.08 | 1 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $129.16 | 1 | $0 (2018) |
| UROGEN PHARMA, INC. | $60.15 | 2 | $0 (2024) |
| Allergan Inc. | $35.30 | 2 | $0 (2017) |
| AXOGEN | $34.85 | 1 | $0 (2017) |
| Boston Scientific Corporation | $32.78 | 2 | $0 (2022) |
| Medtronic USA, Inc. | $23.15 | 2 | $0 (2017) |
| Photocure Inc | $19.83 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $207,044 | 3 | Provepharm Inc. ($206,884) |
| 2022 | $56.20 | 3 | UroGen Pharma, Inc. ($41.66) |
| 2020 | $20.04 | 1 | Astellas Pharma US Inc ($20.04) |
| 2018 | $159.77 | 3 | Dendreon Pharmaceuticals LLC ($129.16) |
| 2017 | $274.11 | 13 | Astellas Pharma US Inc ($131.17) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Provepharm Inc. | BLUDIGO (Drug) | — | Cash or cash equivalent | $206,884.00 | Research |
| Study: PVP-22IC04 and PVP-22IC05 • Category: MARKER DYE | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $141.08 | General |
| Category: Oncology | ||||||
| 01/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/12/2022 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $1.10 | General |
| Category: Kidney Stones | ||||||
| 09/23/2022 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: LithoVue_URO | ||||||
| 05/02/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $41.66 | General |
| Category: UROTHELIAL CANCER | ||||||
| 01/31/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $20.04 | General |
| Category: ONCOLOGY | ||||||
| 12/31/2018 | Photocure Inc | Cysview (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Oncology | ||||||
| 11/19/2018 | Egalet US Inc | SPRIX (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Pain Medicine | ||||||
| 02/13/2018 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $129.16 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/17/2017 | BOSTON SCIENTIFIC CORPORATION | SENSOR (Device) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: GYNECOLOGY | ||||||
| 09/09/2017 | Allergan Inc. | BOTOX OAB (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: OVER ACTIVE BLADDER | ||||||
| 09/06/2017 | Allergan Inc. | BOTOX OAB (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: OVER ACTIVE BLADDER | ||||||
| 08/07/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Oncology | ||||||
| 05/24/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Urology | ||||||
| 05/15/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $55.00 | General |
| 04/17/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Urology | ||||||
| 04/07/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Urology | ||||||
| 03/21/2017 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 03/20/2017 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Prostate Cancer | ||||||
| 03/08/2017 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 02/27/2017 | AXOGEN | AxoGuard Nerve Protector (Device), AxoGuard Nerve Connector | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: Neurology | ||||||
| 02/02/2017 | Valeant Pharmaceuticals North America LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PVP-22IC04 and PVP-22IC05 | Provepharm Inc. | $206,884 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 2,765 | 5,349 | $614,311 | $209,581 |
| 2022 | 34 | 2,627 | 4,686 | $554,915 | $193,507 |
| 2021 | 33 | 2,436 | 4,055 | $488,059 | $167,884 |
| 2020 | 25 | 2,075 | 2,616 | $347,078 | $97,461 |
Total Patients
9,903
Total Services
16,706
Medicare Billing
$668,432
Procedure Codes
129
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 446 | 684 | $147,060 | $60,601 | 41.2% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 96 | 1,584 | $123,552 | $54,096 | 43.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 69 | 90 | $44,100 | $14,776 | 33.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 64 | 272 | $21,780 | $11,130 | 51.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $28,796 | $10,088 | 35.0% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 26 | 26 | $18,200 | $6,730 | 37.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 63 | 65 | $22,425 | $5,262 | 23.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 214 | 268 | $29,480 | $4,813 | 16.3% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 95 | 131 | $10,218 | $4,474 | 43.8% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 96 | 131 | $10,218 | $4,474 | 43.8% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 96 | 131 | $10,218 | $4,474 | 43.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 11 | $22,000 | $3,378 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 50 | $7,500 | $2,907 | 38.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 235 | 320 | $3,200 | $2,680 | 83.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 18 | 18 | $9,000 | $2,304 | 25.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 444 | 678 | $10,170 | $2,089 | 20.5% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 12 | 26 | $7,020 | $1,669 | 23.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 39 | 61 | $9,150 | $1,543 | 16.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 16 | $19,200 | $1,517 | 7.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $3,850 | $1,394 | 36.2% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 12 | 12 | $6,500 | $1,326 | 20.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 167 | 199 | $18,905 | $1,317 | 7.0% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 11 | 11 | $3,850 | $956.27 | 24.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 24 | $2,160 | $910.76 | 42.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 21 | $1,890 | $861.00 | 45.6% |
About Dr. Daniel Yelfimov, M.D
Dr. Daniel Yelfimov, M.D is a Urology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1720309685.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Yelfimov, M.D has received a total of $207,554 in payments from pharmaceutical and medical device companies, with $207,044 received in 2024. These payments were reported across 23 transactions from 14 companies. The most common payment nature is "" ($206,884).
As a Medicare-enrolled provider, Yelfimov has provided services to 9,903 Medicare beneficiaries, totaling 16,706 services with total Medicare billing of $668,432. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location San Antonio, TX
- Active Since 06/15/2010
- Last Updated 01/12/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1720309685
Products in Payments
- BLUDIGO (Drug) $206,884
- PROVENGE (Drug) $148.39
- ERLEADA (Drug) $141.08
- JELMYTO (Drug) $60.15
- Myrbetriq (Drug) $53.85
- BOTOX OAB (Drug) $35.30
- AxoGuard Nerve Protector (Device) $34.85
- INTERSTIM (Device) $23.15
- Xtandi (Drug) $22.32
- XTANDI (Drug) $20.04
- Cysview (Drug) $19.83
- SENSOR (Device) $19.34
- LithoVue (Device) $13.44
- ELIGARD (Drug) $11.07
- SPRIX (Drug) $10.78
- Thiola (Drug) $1.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in San Antonio
Dr. Leroy Jones, Md, MD
Urology — Payments: $720,896
Urology $720,896
Stephen Kraus, Md, MD
Urology — Payments: $515,744
Urology $515,744
Dr. Christopher Cantrill, Md, MD
Urology — Payments: $95,294
Urology $95,294
Dr. Jose De La Cerda, M.d, M.D
Urology — Payments: $92,067
Urology $92,067
Dr. Naveen Kella, M.d, M.D
Urology — Payments: $63,626
Urology $63,626
Robert Svatek, Md, MD
Urology — Payments: $58,084
Urology $58,084